Search Results 91-100 of 8646 for Raloxifene

  1. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  2. Zaleplon (oral route) - Side effects & dosage - Mayo Clinic

    Zaleplon is used to treat insomnia (trouble sleeping). It belongs to the group of medicines called central nervous system (CNS) depressants, which slows down ...

  3. Tamoxifen Citrate, Letrozole, Anastrozole, Or Exemestane With Or Without Chemotherapy In Treating Patients With Invasive RxPONDER Breast Cancer - Mayo Clinic

    ... raloxifene within 5 years prior to registration; Patients must not be pregnant or nursing; women of reproductive potential must have agreed to use an ...

  4. Investigating Magnesium Glycinate In Structure/Function Role Of Hot Flashes. - Mayo Clinic

    Tamoxifen, raloxifene and aromatase inhibitors are allowed, but patient must have been on a constant dose for at least 28 days and must not be expected to ...

  5. Histology of Functional Density in Postmenopausal Breast - Mayo Clinic

    Using any exogenous hormones (e.g., hormonal contraceptives, sex steroid hormones) or any estrogen receptor modulating drugs (e.g., tamoxifen, raloxifene) or ...

  6. A Study To Evaluate Patient And Provider Choices On Incorporating Chemoprevention Into Care - Mayo Clinic

    SERMs: tamoxifen, raloxifene. AIs: anastrozole, exemestane, letrozole. Patients must not be currently taking hormone replacement therapy. Patients must not ...

  7. Hematology - Clinical trials

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  8. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...

  9. Bexarotene (oral route) - Mayo Clinic

    It is used to treat a certain type of cancer called cutaneous T-cell lymphoma. It works by interfering with the growth of the cancerous cells. This medicine is ...

  10. Study To Assess The Blood Concentrations And Actions Of Recombinant Human Parathyroid Hormone (RhPTH [1-84]) When Given Once And Twice Daily To Subjects With Hypoparathyroidism - Mayo Clinic

    6 months: fluoride tablets, oral bisphosphonates, methotrexate growth hormone, digoxin; raloxifene or similar selective estrogen receptor modulators; 12 ...